These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 15531912)
1. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Soung YH; Lee JW; Kim SY; Sung YJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH Oncogene; 2005 Jan; 24(1):141-7. PubMed ID: 15531912 [TBL] [Abstract][Full Text] [Related]
2. CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Soung YH; Lee JW; Kim SY; Jang J; Park YG; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH Cancer Res; 2005 Feb; 65(3):815-21. PubMed ID: 15705878 [TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of caspase-14 gene in common carcinomas. Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas. Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of caspase 1, 4, and 5 genes in common human cancers. Soung YH; Jeong EG; Ahn CH; Kim SS; Song SY; Yoo NJ; Lee SH Hum Pathol; 2008 Jun; 39(6):895-900. PubMed ID: 18430458 [TBL] [Abstract][Full Text] [Related]
6. Inactivating mutations of CASPASE-7 gene in human cancers. Soung YH; Lee JW; Kim HS; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Park YG; Nam SW; Jeong SW; Kim SH; Lee JY; Yoo NJ; Lee SH Oncogene; 2003 Sep; 22(39):8048-52. PubMed ID: 12970753 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. Soung YH; Lee JW; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH APMIS; 2006 Apr; 114(4):292-7. PubMed ID: 16689829 [TBL] [Abstract][Full Text] [Related]
8. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element. Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959 [TBL] [Abstract][Full Text] [Related]
9. Inactivating mutations of proapoptotic Bad gene in human colon cancers. Lee JW; Soung YH; Kim SY; Nam SW; Kim CJ; Cho YG; Lee JH; Kim HS; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH Carcinogenesis; 2004 Aug; 25(8):1371-6. PubMed ID: 15033904 [TBL] [Abstract][Full Text] [Related]
10. Mutations in the BRCA2 gene in hepatocellular carcinomas. Katagiri T; Nakamura Y; Miki Y Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963 [TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of caspase genes in prostate carcinomas. Kim MS; Park SW; Kim YR; Lee JY; Lim HW; Song SY; Yoo NJ; Lee SH APMIS; 2010 Apr; 118(4):308-12. PubMed ID: 20402676 [TBL] [Abstract][Full Text] [Related]
12. PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Lee JW; Soung YH; Kim SY; Lee HW; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH Oncogene; 2005 Feb; 24(8):1477-80. PubMed ID: 15608678 [TBL] [Abstract][Full Text] [Related]
13. Inactivating mutation of the pro-apoptotic gene BID in gastric cancer. Lee JH; Soung YH; Lee JW; Park WS; Kim SY; Cho YG; Kim CJ; Seo SH; Kim HS; Nam SW; Yoo NJ; Lee SH; Lee JY J Pathol; 2004 Apr; 202(4):439-45. PubMed ID: 15095271 [TBL] [Abstract][Full Text] [Related]
14. Inactivating mutations of caspase-8 gene in colorectal carcinomas. Kim HS; Lee JW; Soung YH; Park WS; Kim SY; Lee JH; Park JY; Cho YG; Kim CJ; Jeong SW; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH Gastroenterology; 2003 Sep; 125(3):708-15. PubMed ID: 12949717 [TBL] [Abstract][Full Text] [Related]
15. Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Yin PH; Wu CC; Lin JC; Chi CW; Wei YH; Lee HC Mitochondrion; 2010 Mar; 10(2):174-82. PubMed ID: 20006738 [TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma. Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311 [TBL] [Abstract][Full Text] [Related]
17. Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas. Yoo NJ; Lee JW; Jeong EG; Soung YH; Nam SW; Lee JY; Lee SH Dig Liver Dis; 2006 Sep; 38(9):683-7. PubMed ID: 16807152 [TBL] [Abstract][Full Text] [Related]
18. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Tanaka S; Toh Y; Adachi E; Matsumata T; Mori R; Sugimachi K Cancer Res; 1993 Jun; 53(12):2884-7. PubMed ID: 8389246 [TBL] [Abstract][Full Text] [Related]
19. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062 [TBL] [Abstract][Full Text] [Related]
20. Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. Chen GG; Li MY; Ho RL; Chak EC; Lau WY; Lai PB J Clin Virol; 2005 Sep; 34(1):7-12. PubMed ID: 16087118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]